$237.20+0.99 (+0.42%)
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States.
UFP Technologies, Inc. in the Healthcare sector is trading at $237.20 with a market capitalization of $1.7B. Wall Street consensus targets $324.50 (2 analysts), implying a +36.8% move over the next 12 months. The stock is currently 15% below its 52-week high of $279.49, remaining 6.1% above its 200-day moving average. On fundamentals, Piotroski 8/9 indicates strong financial quality, Altman Z in the safe zone. The Whystock Score of 100/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $154.20M↑ | $148.91M↓ | $154.56M↑ | $151.18M↑ | $148.15M |
| Gross Profit | $44.36M↑ | $41.97M↓ | $42.75M↓ | $43.54M↑ | $42.15M |
| Operating Income | $23.34M↑ | $21.00M↓ | $23.68M↓ | $24.86M↑ | $23.43M |
| Net Income | $17.50M↓ | $17.57M↑ | $16.38M↓ | $17.18M | $17.18M |
UFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company provides protective drapes for robotic surgery, ...
Over the past six months, UFP Technologies’s shares (currently trading at $244.72) have posted a disappointing 8.2% loss, well below the S&P 500’s 7.7% gain. This may have investors wondering how to approach the situation.
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Shareholders who bet on the industry have been rewarded lately as healthcare stocks have returned 11.5% over the past six months, topping the S&P 500 by 4.3 percentage points.
Each stock in this article is trading near its 52-week high. These elevated prices usually indicate some degree of investor confidence, business improvements, or favorable market conditions.
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.
This medical device supplier, known for custom healthcare components, reported a notable insider sale amid ongoing sector diversification.